Literature DB >> 16140008

Improvement in colorectal cancer survival: a population-based study.

Emmanuel Mitry1, Anne-Marie Bouvier, Jacques Esteve, Jean Faivre.   

Abstract

The aim of this study was to explore the reasons for improvement in colorectal cancer survival. Trends in relative survival among 5874 patients diagnosed with colorectal cancer over a 24-year period in a well-defined French population were analysed. The 5-year relative survival rate, excluding operative mortality, increased from 49.2% to 56.3% between the periods 1976-1987 and 1988-1999. In multivariate analysis, stage at diagnosis and adjuvant chemotherapy were both associated with better survival after surgery with curative intent. Survival trends differed markedly by age. The improvement in overall survival for older patients can be attributed to the increase in the proportion of patients resected for cure. For younger patients, there was an increase in the proportion of patients operated for cure, but also an improvement in stage-specific survival, particularly for stage III tumours, suggesting an impact of adjuvant chemotherapy.

Entities:  

Mesh:

Year:  2005        PMID: 16140008     DOI: 10.1016/j.ejca.2005.01.028

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  21 in total

1.  The Impact of Improved Population Life Expectancy in Survival Trend Analyses of Specific Diseases.

Authors:  Carl van Walraven
Journal:  Health Serv Res       Date:  2015-10-20       Impact factor: 3.402

2.  Increasing age-related survival gap among patients with colorectal cancer: a population-based retrospective study.

Authors:  Yang Feng; Shaobo Mo; Weixing Dai; Qingguo Li; Guoxiang Cai; Sanjun Cai
Journal:  Int J Clin Oncol       Date:  2019-09-17       Impact factor: 3.402

3.  Cancer incidence and mortality projections up to 2020 in Catalonia by means of Bayesian models.

Authors:  J Ribes; L Esteban; R Clèries; J Galceran; R Marcos-Gragera; R Gispert; A Ameijide; M L Vilardell; J Borras; A Puigdefabregas; M Buxó; A Freitas; A Izquierdo; J M Borras
Journal:  Clin Transl Oncol       Date:  2013-12-12       Impact factor: 3.405

4.  The effect of marital status by age on patients with colorectal cancer over the past decades: a SEER-based analysis.

Authors:  Yang Feng; Weixing Dai; Yaqi Li; Shaobo Mo; Qingguo Li; Sanjun Cai
Journal:  Int J Colorectal Dis       Date:  2018-03-15       Impact factor: 2.571

Review 5.  Treatment of older patients with colorectal cancer: a perspective review.

Authors:  Z Kordatou; P Kountourakis; Demetris Papamichael
Journal:  Ther Adv Med Oncol       Date:  2014-05       Impact factor: 8.168

6.  Surveillance of anal carcinoma after radiochemotherapy : A retrospective analysis of 80 patients.

Authors:  Matthias Sauter; Stephan R Vavricka; Georg Keilholz; Henriette Heinrich; Thomas Winder; Helmut Kranzbühler; Norbert Lombriser; Benjamin Misselwitz
Journal:  Strahlenther Onkol       Date:  2017-06-26       Impact factor: 3.621

7.  Net survival of patients with colorectal cancer: a comparison of two periods.

Authors:  Zdravko Štor; Rok Blagus; Alessandro Tropea; Antonio Biondi
Journal:  Updates Surg       Date:  2019-06-12

Review 8.  Role of the antiangiogenic agent bevacizumab in the treatment of elderly patients with metastatic colorectal cancer.

Authors:  Maria Di Bartolomeo; Filippo Pietrantonio; Antonia Martinetti; Roberto Buzzoni; Arpine Gevorgyan; Emilio Bajetta
Journal:  Drugs Aging       Date:  2011-02-01       Impact factor: 3.923

9.  Complete response to capecitabine in a frail, elderly patient with metastatic colorectal cancer: A case report.

Authors:  Morena Fasano; Alessio Fabozzi; Guido Giordano; Filippo Venturini; Gaetano Aurilio; Flavia Cantile; Teresa Fabozzi; Vincenzo Ricci; Giuseppe Santabarbara; Floriana Morgillo; Fortunato Ciardiello; Ferdinando De Vita
Journal:  Oncol Lett       Date:  2016-12-20       Impact factor: 2.967

Review 10.  Colon cancer and the elderly: from screening to treatment in management of GI disease in the elderly.

Authors:  Peter R Holt; Peter Kozuch; Seetal Mewar
Journal:  Best Pract Res Clin Gastroenterol       Date:  2009       Impact factor: 3.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.